Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KPRX US Equity

Kiora Pharmaceuticals IncHealth Care · Pharmaceutical Preparations · CIK 1372514 · FY ends Dec 31
$2.60
+0.01 (+0.39%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-12-312026-03-25none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We are not currently a party to any legal proceedings, however, from time to time we may be a party to a variety of legal proceedings that arise in the normal course of our business.

Item 9A · ICFR · As a result of that evaluation, management concluded our internal control over financial reporting was effective as of December 31, 2025.

Item 9A · disclosure controls · Based upon the evaluation described above,with reasonable assurance, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures that support financial reporting were effective as of the period ended December 31, 2025.

2024-12-312025-03-25none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · We are not currently a party to any legal proceedings, however, from time to time we may be a party to a variety of legal proceedings that arise in the normal course of our business.

Item 9A · ICFR · As a result of that evaluation, management concluded our internal control over financial reporting was effective as of December 31, 2024.

Item 9A · disclosure controls · Based upon the evaluation described above,with reasonable assurance, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures that support financial reporting were effective as of the period ended December 31, 2024.

2023-12-312024-03-25none statednot extractednot extracteddisclosedEDGAR

Item 3 · We are not currently a party to any legal proceedings, however, from time to time we may be a party to a variety of legal proceedings that arise in the normal course of our business.

Item 9A · ICFR · As a result of that evaluation, management concluded our internal control over financial reporting was effective as of December 31, 2023.

Item 9A · disclosure controls · Based upon the evaluation described above, our Chief Executive Officer and Executive Vice President of Finance have concluded that our disclosure controls and procedures that support financial reporting were effective as of the period ended December 31, 2023.

Item 9A · material weakness · Changes in Internal Control over Financial Accounting and Reporting As disclosed in Part II, Item 9A of the Company's Annual Report on Form 10-K for the year ended December 31, 2022, our Chief Executive Officer and Executive Vice President of Finance concluded that our internal control over financial reporting was not effective as of December 31, 2022 due to the following material weaknesses: 1) information technology general controls which could result in misstatements potentially impacting all financial statement accounts and disclosures.

2022-12-312023-03-23none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · While we are not currently a party to any legal proceedings, from time to time we may be a party to a variety of legal proceedings that arise in the normal course of our business.

Item 9A · ICFR · As a result of that evaluation, management concluded our internal control over financial reporting was not effective as of December 31, 2022.

Item 9A · disclosure controls · Based upon the evaluation described above, our Chief Executive Officer and Executive Vice President of Finance have concluded that our disclosure controls and procedures that support financial reporting were not effective as of the period ending December 31, 2022 due to material weaknesses described below.

2021-12-312022-04-15none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · While we are not currently a party to any legal proceedings, from time to time we may be a party to a variety of legal proceedings that arise in the normal course of our business.

Item 9A · ICFR · As a result of that evaluation, management concluded our internal control over financial reporting was not effective as of December 31, 2021 due to the material weaknesses described below.

Item 9A · disclosure controls · Based upon the evaluation described above, our Chief Executive Officer concluded that our disclosure controls and procedures were not effective as of the end of the period described by this report due to material weaknesses identified in our internal control over financial reporting, described below.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.